SLA Pharma, a company focused solely on developing medicines for the treatment of gastrointestinal disorders, is making Ortem™, a proprietary preparation of metronidazole 10% ointment, available to UK hospitals as an unlicensed medicine.
SLA Pharma has partnered with Leith Healthcare to provide UK customer support for Ortem™.
Leith Healthcare will provide medical information, pharmacovigilance reporting, and will ensure that relevant hospital teams involved in the care of patients with gastrointestinal disorders, are aware of Ortem™ pricing and availability.
Ortem™ 30g tubes are expected to be in stock and available via Prulab Pharma through Oxford Pharmacy Stores from May 2023.
Contacts
Leith Healthcare – Richard Baderin, Managing Director [email protected]
SLA Pharma – Justin Slagel, CEO. [email protected]
